Get started
Author

Jaime González‐Montero

Observed names: J. González-Montero, J., González-Montero, Jaime A. González Montero, Jaime Gonzalez-Montero, Jaime González, Jaime González-Montero, Mauricio Burotto
ORCID: 0000-0003-0324-2948
Observed ORCID: 0000-0003-0324-2948
OpenAlex ID: A5073068359
Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities
2018 · Jaime González-Montero, Roberto Brito, et al. · World Journal of Cardiology · 179
PDF
Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
2021 · Guillermo Valenzuela, Joaquín Canepa, et al. · World Journal of Clinical Oncology · 58
PDF
Predictors of response to immunotherapy in colorectal cancer
2024 · Jaime González-Montero, Carlos I Rojas, et al. · The Oncologist · 36
Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back
2022 · Jaime González-Montero, Silvia Chichiarelli, et al. · Molecules · 30
PDF
Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation
2021 · Ramón Rodrigo, Jaime González-Montero, et al. · Biomedicines · 27
PDF
Management of cancer patients during COVID-19 pandemic at developing countries
2020 · Jaime González-Montero, Guillermo Valenzuela, et al. · World Journal of Clinical Cases · 27
PDF
Effects of a novel ascorbate-based protocol on infarct size and ventricle function in acute myocardial infarction patients undergoing percutaneous coronary angioplasty
2016 · Cristóbal Ramos, Roberto Brito, et al. · Archives of Medical Science · 24
PDF
MAP4K4 and cancer: ready for the main stage?
2023 · Jaime González-Montero, Carlos I. Rojas, et al. · Frontiers in Oncology · 16
PDF
Current landscape in first-line treatment of metastatic hormone sensitive prostate cancer: a cost-effectiveness focused review
2025 · Cristóbal Ávila, Jaime González-Montero, et al. · The Oncologist · 13
PDF
Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management
2024 · Alejandro Valdés, Gonzalo Pizarro, et al. · Expert Review of Clinical Pharmacology · 12
Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment
2025 · Guillermo Valenzuela, Héctor R. Contreras, et al. · International Journal of Molecular Sciences · 10
PDF
Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer
2022 · Guillermo Valenzuela, Mauricio Burotto, et al. · World Journal of Gastrointestinal Oncology · 8
Distinct Driver Pathway Enrichments and a High Prevalence of TSC2 Mutations in Right Colon Cancer in Chile: A Preliminary Comparative Analysis
2024 · Camilo Tapia-Valladares, Guillermo Valenzuela, et al. · International Journal of Molecular Sciences · 4
PDF
Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
2023 · Jaime González-Montero, Mauricio Burotto, et al. · World Journal of Clinical Oncology · 4
Sidedness matters: Colon cancer outcomes in low-resource settings
2025 · Jaime González-Montero, Guillermo Valenzuela, et al. · World Journal of Clinical Oncology · 3
Subcutaneous atezolizumab for the treatment of non-small cell lung cancer
2026 · Jaime González-Montero, Carlos I. Rojas, et al. · Therapeutic Delivery · 1
Immunotherapy-Related Pancreatitis: A Case Series of 8 Patients from a High-Volume Oncology Centre
2025 · Tomás San Martín, Jaime González-Montero, et al. · Case Reports in Oncology · 1
Considerations on the implementation of MAP4K4 inhibitors as cancer treatment
2024 · Jaime Gonzalez-Montero, Mauricio Burotto · Expert Opinion on Therapeutic Targets · 1
JAK2V617F mutation prevalence on Chilean adults suffering from primary mesenteric and portal venous thromboses
2020 · Jaime González‐Montero, Lucía Del Valle‐Batalla, et al. · International Journal of Laboratory Hematology · 1
Primary Liver Cancer and Other Malignancies in Alcohol Use Disorder and Alcohol‐Associated Liver Disease
2026 · Gonzalo Pizarro, Bastian Alcayaga, et al. · Liver International
PDF
TraceLab: Twelve Months of Real-World Digital Traceability for Biological Samples at a Chilean Clinical Research Center
2026 · Kevin Ramírez, Gerardo Venegas, et al. · Biopreservation and Biobanking
Immune-Mediated Membranoproliferative Glomerulonephritis during Pembrolizumab plus Bevacizumab Therapy in High-Grade Serous Ovarian Cancer: A Case Report
2026 · Michel Contreras, Rossana Reina, et al. · Case Reports in Oncology
PDF
Supplementary Material for: Immune-Mediated Membranoproliferative Glomerulonephritis during pembrolizumab plus bevacizumab Therapy in High-Grade Serous Ovarian Cancer: A Case Report
2026 · figshare admin karger, Michel Contreras, et al. · Figshare
The use of miR-5193 to predict oxaliplatin chemosensitivity in colorectal cancer: Integrated in silico, in vitro, and clinical evidence.
2026 · Jaime A. González Montero, Guillermo Valenzuela, et al. · Journal of Clinical Oncology
First-Line Treatment Strategies in IMDC Favourable-Risk Metastatic Clear Cell Renal Cell Carcinoma
2026 · Alejandro Valdés, Jaime González-Montero, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
PDF
Works count: 30
Citation count: 455
H-index: 10
I10-index: 11
Year
Topic
Type